Last reviewed · How we verify
LAT8881
At a glance
| Generic name | LAT8881 |
|---|---|
| Sponsor | Lateral Pharma Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain (PHASE1)
- Oral LAT8881 in Neuropathic Pain (PHASE2)
- A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LAT8881 CI brief — competitive landscape report
- LAT8881 updates RSS · CI watch RSS
- Lateral Pharma Pty Ltd portfolio CI